The EDC is live today — see what ships now
All studies
NCT06937229From ClinicalTrials.govRecruiting

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

A Phase 3, Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-3)

  • Alzheimer Disease
  • Agitation

At a glance

Phase
Phase 3
Study type
Interventional
Sponsor
Bristol-Myers Squibb
Enrolment target
650
Started
2 December 2025
Main results due
22 June 2029
Study sites
252
Registry updated
28 September 2026

Can you take part?

  • Ages 55 years to 90 years.
  • Open to any sex.
  • You need the condition being studied — healthy volunteers are not accepted.

These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.

Read the full eligibility criteria
Inclusion Criteria:

* Participants must have completed study CN012-0023 or CN012-0024 per protocol.
* Participants must have an identified caregiver who has sufficient contact (approximately 8 hours over a week).

Exclusion Criteria:

* Participants must not have clinically significant cardiovascular (eg, untreated or unstable hypertension, clinically significant tachycardia), pulmonary, renal, hematologic, GI, endocrine, immunologic, dermatologic, neurologic, or oncologic disease or any other condition that, in the opinion of the investigator, would jeopardize the safety of the participant or the validity of the study results.
* Other protocol-defined Inclusion/Exclusion criteria apply.

What this study is about

In the sponsor’s own words, from the registry.

The purpose of this study is to evaluate the long-term efficacy and safety of combined formulation of xanomeline tartrate/trospium chloride in an immediate release (IR) capsule (KarXT) and xanomeline enteric capsules (KarX-EC) in participants with agitation associated with Alzheimer's Disease who completed the parent studies CN012-0023 or CN012-0024.

Study sites(252)

  • Local Institution - 2609

    Chandler, Arizona, United States

    Not yet recruiting

  • Imaging Endpoints

    Scottsdale, Arizona, United States

    Recruiting

  • Local Institution - 1657

    Anaheim, California, United States

    Not yet recruiting

  • Local Institution - 1668

    Fresno, California, United States

    Not yet recruiting

  • Local Institution - 2625

    Long Beach, California, United States

    Not yet recruiting

  • Local Institution - 2642

    Long Beach, California, United States

    Not yet recruiting

  • Local Institution - 2649

    Orange, California, United States

    Not yet recruiting

  • Local Institution - 2613

    Pasadena, California, United States

    Not yet recruiting

  • Local Institution - 1662

    Pomona, California, United States

    Not yet recruiting

  • Local Institution - 1639

    Torrance, California, United States

    Not yet recruiting

  • Local Institution - 1651

    Walnut Creek, California, United States

    Not yet recruiting

  • Local Institution - 2602

    Bonita Springs, Florida, United States

    Not yet recruiting

  • Nuovida Research Center

    Miami, Florida, United States

    Recruiting

  • Local Institution - 1635

    Orlando, Florida, United States

    Not yet recruiting

  • Progressive Medical Research

    Port Orange, Florida, United States

    Recruiting

  • IPTB Clinical Research

    Tampa, Florida, United States

    Recruiting

  • Hope Research Network - Miami

    Virginia Gardens, Florida, United States

    Recruiting

  • Local Institution - 2611

    Atlanta, Georgia, United States

    Not yet recruiting

  • Local Institution - 1636

    Gaithersburg, Maryland, United States

    Not yet recruiting

  • Boston Center for Memory

    Newton, Massachusetts, United States

    Recruiting

  • Local Institution - 2615

    Worcester, Massachusetts, United States

    Not yet recruiting

  • Local Institution - 1620

    Troy, Michigan, United States

    Not yet recruiting

  • Local Institution - 2256

    Saint Paul, Minnesota, United States

    Not yet recruiting

  • Local Institution - 2629

    Hattiesburg, Mississippi, United States

    Not yet recruiting

  • Local Institution - 2628

    Las Vegas, Nevada, United States

    Not yet recruiting

  • Redbird Research

    Las Vegas, Nevada, United States

    Recruiting

  • Local Institution - 1664

    Princeton, New Jersey, United States

    Not yet recruiting

  • Local Institution - 1656

    New Windsor, New York, United States

    Not yet recruiting

  • Local Institution - 2619

    Staten Island, New York, United States

    Not yet recruiting

  • Local Institution - 1658

    Woodmere, New York, United States

    Not yet recruiting

  • West Clinical Research

    Morehead City, North Carolina, United States

    Recruiting

  • Local Institution - 2617

    Blue Ash, Ohio, United States

    Not yet recruiting

  • Local Institution - 1640

    Tulsa, Oklahoma, United States

    Not yet recruiting

  • Epic Medical Research, LLC - Carrolton

    Carrollton, Texas, United States

    Recruiting

  • Local Institution - 2605

    Cypress, Texas, United States

    Not yet recruiting

  • Local Institution - 1643

    El Paso, Texas, United States

    Not yet recruiting

  • Local Institution - 2622

    Mesquite, Texas, United States

    Not yet recruiting

  • Local Institution - 2623

    San Antonio, Texas, United States

    Not yet recruiting

  • Local Institution - 2612

    Bountiful, Utah, United States

    Completed

  • Local Institution - 1646

    Bennington, Vermont, United States

    Not yet recruiting

  • Local Institution - 1644

    Seattle, Washington, United States

    Not yet recruiting

  • Local Institution - 2610

    Milwaukee, Wisconsin, United States

    Not yet recruiting

  • Local Institution - 2005

    Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina

    Not yet recruiting

  • Local Institution - 1001

    La Plata, Buenos Aires, Argentina

    Not yet recruiting

  • Local Institution - 1002

    Mar del Plata, Buenos Aires, Argentina

    Not yet recruiting

  • Local Institution - 2006

    Buenos Aires, Buenos Aires F.D., Argentina

    Not yet recruiting

  • Local Institution - 1006

    Rosario, Santa Fe Province, Argentina

    Not yet recruiting

  • Local Institution - 2004

    Buenos Aires, Argentina

    Not yet recruiting

  • Local Institution - 1003

    Buenos Aires, Argentina

    Not yet recruiting

  • Local Institution - 1004

    Córdoba, Argentina

    Not yet recruiting

  • Local Institution - 2000

    Córdoba, Argentina

    Not yet recruiting

  • Local Institution - 2002

    Córdoba, Argentina

    Not yet recruiting

  • Local Institution - 1005

    Córdoba, Argentina

    Not yet recruiting

  • Local Institution - 1000

    Córdoba, Argentina

    Not yet recruiting

  • Local Institution - 2003

    Córdoba, Argentina

    Not yet recruiting

  • Local Institution - 2001

    Mendoza, Argentina

    Not yet recruiting

  • Local Institution - 1051

    Brasília, Federal District, Brazil

    Not yet recruiting

  • Local Institution - 1052

    Curitiba, Paraná, Brazil

    Not yet recruiting

  • Local Institution - 1053

    Curitiba, Paraná, Brazil

    Not yet recruiting

  • Local Institution - 1058

    Porto Alegre, Rio Grande do Sul, Brazil

    Not yet recruiting

Showing 60 of 252 sites — filter to narrow it down. 51 of the 252 sites on this study are recruiting right now — a site can stop enrolling while the study as a whole is still open.

Source: ClinicalTrials.gov record NCT06937229. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.

Not the right study?

Answer three questions and see the studies recruiting near you, in plain language.

Find a study for me
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease | Trialion